C-Reactive Protein: Clinical and Epidemiological Perspectives
Open Access
- 6 February 2014
- journal article
- review article
- Published by Hindawi Limited in Cardiology Research and Practice
- Vol. 2014, 1-10
- https://doi.org/10.1155/2014/605810
Abstract
An important etiopathogenic component of cardiovascular disease is atherosclerosis, with inflammation being an essential event in the pathophysiology of all clinical pictures it comprises. In recent years, several molecules implicated in this process have been studied in order to assess cardiovascular risk in both primary and secondary prevention. C-reactive protein is a plasmatic protein of the pentraxin family and an acute phase reactant, very useful as a general inflammation marker. Currently, it is one of the most profoundly researched molecules in the cardiovascular field, yet its clinical applicability regarding cardiovascular risk remains an object of discussion, considered by some as a simple marker and by others as a true risk factor. In this sense, numerous studies propose its utilization as a predictor of cardiovascular risk through the use of high-sensitivity quantification methods for the detection of valuesKeywords
This publication has 100 references indexed in Scilit:
- Immunity, atherosclerosis and cardiovascular diseaseBMC Medicine, 2013
- Association between Serum Interleukin-6 Concentration and Mortality in Patients with Coronary Artery DiseaseMediators of Inflammation, 2013
- Long Pentraxin 3: Experimental and Clinical Relevance in Cardiovascular DiseasesMediators of Inflammation, 2013
- Association of high sensitive C-reactive protein (hsCRP) with established cardiovascular risk factors in the Indian populationNutrition & Metabolism, 2011
- Lipoprotein(a) as a cardiovascular risk factor: current statusEuropean Heart Journal, 2010
- C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysisThe Lancet, 2010
- C-Reactive Protein and Parental History Improve Global Cardiovascular Risk PredictionCirculation, 2008
- C-reactive protein exerts angiogenic effects on vascular endothelial cells and modulates associated signalling pathways and gene expressionBMC Cell Biology, 2008
- General Cardiovascular Risk Profile for Use in Primary CareCirculation, 2008
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001